Thompson Rahsaan
Chief Legal & Compliance
Thompson Rahsaan has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Aug 17, 2026.
On the most recent filing, Thompson Rahsaan is listed as Chief Legal & Compliance at ZEVRA THERAPEUTICS, INC. Inside the rolling window, Thompson Rahsaan reported no open-market purchases and 4 open-market sales totaling $969K in ZVRA. The largest disclosed transaction in the window is a sale of 42,666 ZVRA shares on Aug 14, 2026, worth $475K.
Companies traded
Other insiders at ZVRA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$969K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Thompson Rahsaan made?
Thompson Rahsaan has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Thompson Rahsaan trade?
Thompson Rahsaan has filed SEC Form 4 disclosures for 1 company, including ZVRA.
When was Thompson Rahsaan's most recent SEC Form 4 filing?
Thompson Rahsaan's most recent SEC Form 4 filing on Tracefour is dated Aug 17, 2026.
What is Thompson Rahsaan's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Thompson Rahsaan is listed as Chief Legal & Compliance.
What is Thompson Rahsaan's total buy and sell value in the current window?
Inside the rolling retention window, Thompson Rahsaan bought $0 and sold $969K based on SEC Form 4 filings.
What was Thompson Rahsaan's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 42,666 ZVRA shares on 2026-08-14, worth $475K, per SEC Form 4 filings.